Henry Ford Health System - Hemophilia and Thrombosis Treatment Center is a clinical research site located in Detroit, Michigan, United States 48202-2689.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Henry Ford Health System - Hemophilia and Thrombosis Treatment Center has participated in 2 clinical trials.
Therapeutic areas: Hematological Malignancies, Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis.
Sponsors: Kangpu Biopharmaceuticals, Ltd., Galectin Therapeutics Inc..
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Henry Ford Health System - Hemophilia and Thrombosis Treatment Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Henry Ford Health System - Hemophilia and Thrombosis Treatment Center has 2 clinical trials on record. Their work covers Hematological Malignancies, Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis.
Henry Ford Health System - Hemophilia and Thrombosis Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.